Compare Mutual Funds

Pros
Among most bought funds within the category.

Among most bought funds within the category.

Larger AUM within category.

Larger AUM within category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Cons

-

-

INDMoney rank
-
6/8
Category

Equity, Sector - Healthcare

Equity, Sector - Healthcare

Fund Age

2 Years 6 Months

13 Years 5 Months

Fund AUM

₹2031 Cr

₹8306 Cr

Min Investment
  1. SIP ₹100
  2. Lumpsum ₹100
  1. SIP ₹100
  2. Lumpsum ₹5000
Expense Ratio

0.93%

0.91%

Exit Load

1%

1%

Benchmark Index

BSE Healthcare TR INR

BSE Healthcare TR INR

No of Holdings

31

39

Top 5 Holdings
  1. Sun Pharmaceuticals Industries Ltd(9.81%)
  2. Divi's Laboratories Ltd(8.38%)
  3. Glenmark Pharmaceuticals Ltd(6.62%)
  4. Lupin Ltd(6.44%)
  5. Max Healthcare Institute Ltd Ordinary Shares(6.36%)
  1. Sun Pharmaceuticals Industries Ltd(13.08%)
  2. Lupin Ltd(7.99%)
  3. Divi's Laboratories Ltd(6.56%)
  4. Dr Reddy's Laboratories Ltd(5.81%)
  5. Cipla Ltd(5.67%)
No of Sectors

2

1

Top 3 Sectors
  1. Health(96.33%)
  2. Basic Materials(3.67%)

Health

(100%)

Equity %

98.24%

99.7%

Debt %

-

-

P/E

44.86

35.73

P/B

6.81

5.7

Credit Quality

-

-

Modified Duration

-

-

YTM

-

-

1-Month Return

-2.58%

-2.91%

3-Month Return

0.2%

-1.77%

6-Month Return

1.25%

-1.1%

1-Year Return

8.74%

3.24%

3-Year Return

-

24.53%

5-Year Return

-

16.64%

Sharpe

-

1.17

Alpha

-

0.22

Beta

-

0.9

Standard Deviation

-

15.21

Information Ratio

-

-0.47

Description

HDFC Pharma and Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Dhruv Muchhal, Nikhil Mathur

Sailesh Raj Bhan, Kinjal Desai, Lokesh Maru, Divya Sharma

Most Popular Comparisons